Summary of Significant Accounting Policies (Details) $ / shares in Units, $ in Thousands			1 Months Ended			12 Months Ended
	Oct. 11, 2024 USD ($)	Jul. 19, 2024	Sep. 30, 2023 USD ($) $ / shares shares	Nov. 30, 2022 USD ($)	Apr. 30, 2020	Dec. 31, 2025 USD ($) shares	Dec. 31, 2024 USD ($) shares	Dec. 31, 2023 USD ($)	Oct. 31, 2024 shares	Dec. 31, 2022 USD ($)
Policies
Net Income (Loss)						$ (208,160)	$ (190,426)	$ (434,801)
Accumulated deficit						2,776,022	2,567,862
Cash, cash equivalents and restricted cash						1,076,140	945,587	$ 642,095		$ 466,091
Marketable securities							22,689
Short-term Credit Line, outstanding balance						80,323	$ 80,362
Collateral amount						150,000
Remaining borrowing capacity						$ 20,000
Common stock, shares issued | shares			4,550,000			139,693,000	132,646,000		7,532,300
Stock issued (in dollars per share) | $ / shares			$ 55
Payment of offering expenses			$ 400			$ 112
Proceeds from issuance of common stock			$ 235,800
Convertible note
Policies
Per annum interest rate (as a percent)	2.25%	2.25%			2.25%
Percentage of principal amount converted	100.00%	100.00%
Convertible notes payable	$ 287,400
Convertible to shares of common stock	7,500
Proceeds from notes payable	$ 100
Line Of Credit-UBS
Policies
Borrowings under credit facility				$ 30,000
Collateral amount						150,000
Remaining borrowing capacity						$ 20,000
Equity offering
Policies
Common stock, shares issued | shares			4,550,000